Medtronic InPen has been approved by the FDA, becoming the only smart Type II insulin pen

Medtronic's InPen is currently the only smart insulin pen approved by the FDA, specifically designed for patients with type 1 and type 2 diabetes. Its core features include:
Track real-time levels of active insulin;
Make dosage recommendations based on CGM data;
Provide reminders for missed doses and suggestions for dose correction.
Real-world data shows that after using InPen, patients' duration within the target blood glucose range increased by an average of 2.3% to 5%, without experiencing hypoglycemic events.